Regeneron Pharmaceuticals Uncategorized Contracts & Agreements

53 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment Agreement to License and Collaboration Agreement between Regeneron Pharmaceuticals, Inc. and Bayer Healthcare LLC (May 7, 2012)
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2025
Amendment No. 3 to Master Agreement between Regeneron Pharmaceuticals, Inc. and Alnylam Pharmaceuticals, Inc.
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2024
Amendment No. 2 to Master Agreement between Regeneron Pharmaceuticals, Inc. and Alnylam Pharmaceuticals, Inc.
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2024
Amendment No. 1 to Master Agreement between Regeneron Pharmaceuticals, Inc. and Alnylam Pharmaceuticals, Inc.
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2023
Project Agreement for Large-Scale Manufacturing of Antibodies Directed to SARS-CoV-2 between Advanced Technology International and Regeneron Pharmaceuticals, Inc.
Development Agreements
Regeneron Pharmaceuticals
Biotechnology
2021
Project Agreement for Large-Scale Manufacturing of Antibodies Directed to SARS-CoV-2 between Advanced Technology International and Regeneron Pharmaceuticals, Inc.
Development Agreements
Regeneron Pharmaceuticals
Biotechnology
2020
Base Agreement Between Advanced Technology International and Regeneron Pharmaceuticals, Inc. for Medical CBRN Defense Consortium Participation
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
2020
Amendment to Investor Agreement between Regeneron Pharmaceuticals, Inc. and Sanofi (May 25, 2020)
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2020
Second Amendment Agreement to License and Collaboration Agreement between Regeneron Ireland DAC and Bayer Healthcare LLC
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2020
Description of Regeneron Pharmaceuticals, Inc. Common Stock and Registration Rights Agreement with Sanofi
Registration Rights Agreements
Regeneron Pharmaceuticals
Biotechnology
2020
Master Collaboration Agreement between Alnylam Pharmaceuticals, Inc. and Regeneron Pharmaceuticals, Inc. (April 8, 2019)
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2019
Investor Agreement between Regeneron Pharmaceuticals, Inc. and Alnylam Pharmaceuticals, Inc. dated April 8, 2019
Investor Rights Agreements
Regeneron Pharmaceuticals
Biotechnology
MA
2019
Letter Agreement for Limited Waiver and Amendment among Regeneron Pharmaceuticals, Inc., Sanofi, and Affiliates
Waiver Agreements
Regeneron Pharmaceuticals
Biotechnology
2018
Regeneron Pharmaceuticals, Inc. Non-Qualified Stock Option Agreement with P. Roy Vagelos
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2016
Regeneron Pharmaceuticals, Inc. Non-Qualified Stock Option Agreement for Time-Based Vesting (2014 Long-Term Incentive Plan)
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2015
Second Amendment to Warrant Transaction Agreement between Goldman, Sachs & Co. and Regeneron Pharmaceuticals, Inc.
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2015
Amendment to Warrant Agreement between Morgan Stanley & Co. International plc and Regeneron Pharmaceuticals, Inc. (May 16, 2014)
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2014
Amendment to Warrant Agreement between Goldman, Sachs & Co. and Regeneron Pharmaceuticals, Inc. (May 15, 2014)
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2014
Amendment to Warrant Agreement between Citibank, N.A. and Regeneron Pharmaceuticals, Inc. (May 13, 2014)
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2014
Amended and Restated Investor Agreement among Sanofi, Affiliates, and Regeneron Pharmaceuticals, Inc. (January 11, 2014)
Investor Rights Agreements
Regeneron Pharmaceuticals
Biotechnology
DE
2014
Settlement Agreement Among Bayer, Regeneron, and Genentech Regarding Patent Litigation Over Eylea
Settlement Agreements
Regeneron Pharmaceuticals
Biotechnology
2013
Letter Agreement Regarding PDGF Products Between Regeneron Pharmaceuticals, Inc. and Aventis Pharmaceuticals Inc. (Sanofi)
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2013
Amendment Agreement to License and Collaboration Agreement between Regeneron Pharmaceuticals, Inc. and Bayer Healthcare LLC (May 7, 2012)
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2012
Master Terms and Conditions for Base Additional Warrants between Regeneron Pharmaceuticals, Inc. and Morgan Stanley & Co. International plc
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2011
Master Terms and Conditions for Convertible Bond Hedging Transactions between Morgan Stanley & Co. International plc and Regeneron Pharmaceuticals, Inc.
Financing Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2011
Master Terms and Conditions for Base Warrants between Regeneron Pharmaceuticals, Inc. and Credit Suisse International
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2011
Master Terms and Conditions for Base Warrants between Regeneron Pharmaceuticals, Inc. and Citibank, N.A.
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2011
Master Terms and Conditions for Convertible Bond Hedging Transactions between Citibank, N.A. and Regeneron Pharmaceuticals, Inc.
Financing Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2011
Master Terms and Conditions for Base Warrants between Regeneron Pharmaceuticals, Inc. and Goldman, Sachs & Co.
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2011
Master Terms and Conditions for Convertible Bond Hedging Transactions between Goldman, Sachs & Co. and Regeneron Pharmaceuticals, Inc.
Financing Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2011
First Amendment to December 20, 2007 Investor Agreement by and among sanofi-aventis, Sanofi US, Aventis, sanofi-aventis Amérique du Nord, and Regeneron Pharmaceuticals, Inc.
Investor Rights Agreements
Regeneron Pharmaceuticals
Biotechnology
2010
Regeneron Pharmaceuticals, Inc. Non-Qualified Stock Option Agreement for Performance Vesting Awards
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2009
Description of Regeneron Pharmaceuticals, Inc. Common and Class A Stock Registered Under Section 12 of the Exchange Act
Regeneron Pharmaceuticals
Biotechnology
2025
Consent and Amendment No. 1 Memorandum to Credit Agreement among Regeneron Pharmaceuticals, Inc., JPMorgan Chase Bank, N.A., and Lenders
Regeneron Pharmaceuticals
Biotechnology
2017
Regeneron Pharmaceuticals, Inc. Incentive Stock Option Agreement for P. Roy Vagelos
Stock Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2016
Regeneron Pharmaceuticals, Inc. Restricted Stock Award Agreement under 2014 Long-Term Incentive Plan
Equity Distribution Agreements
Regeneron Pharmaceuticals
Biotechnology
2015
Regeneron Pharmaceuticals, Inc. Incentive Stock Option Agreement for Employee Time-Vesting Awards
Stock Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2015
Restated Amendment Agreement Between Regeneron Pharmaceuticals, Inc. and Bayer Healthcare LLC (May 7, 2012)
Regeneron Pharmaceuticals
Biotechnology
2015
Sixth Amendment to Lease Agreement between BMR-Landmark at Eastview LLC and Regeneron Pharmaceuticals, Inc.
Lease Agreements
Regeneron Pharmaceuticals
Biotechnology
2010
Third Amendment to Lease Agreement between BMR-Landmark at Eastview LLC and Regeneron Pharmaceuticals, Inc.
Lease Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2009